Portal de Periódicos da CAPES

Regional distribution of serotonin transporter protein in postmortem human brain

2005; Elsevier BV; Volume: 32; Issue: 2 Linguagem: Inglês

10.1016/j.nucmedbio.2004.10.001

1872-9614

Stephen J. Kish, Yoshiaki Furukawa, Li‐Jan Chang, Junchao Tong, Nathalie Ginovart, Alan A. Wilson, Sylvain Houle, Jeffrey H. Meyer,

Forensic Toxicology and Drug Analysis

The primary approach in assessing the status of brain serotonin neurons in human conditions such as major depression and exposure to the illicit drug ecstasy has been the use of neuroimaging procedures involving radiotracers that bind to the serotonin transporter (SERT). However, there has been no consistency in the selection of a “SERT-free” reference region for the estimation of free and nonspecific binding, as occipital cortex, cerebellum and white matter have all been employed. To identify areas of human brain that might have very low SERT levels, we measured, by a semiquantitative Western blotting procedure, SERT protein immunoreactivity throughout the postmortem brain of seven normal adult subjects. Serotonin transporter could be quantitated in all examined brain areas. However, the SERT concentration in cerebellar cortex and white matter were only at trace values, being approximately 20% of average cerebral cortex and 5% of average striatum values. Although none of the examined brain areas are completely free of SERT, human cerebellar cortex has low SERT binding as compared to other examined brain regions, with the exception of white matter. Since the cerebellar cortical SERT binding is not zero, this region will not be a suitable reference region for SERT radioligands with very low free and nonspecific binding. For SERT radioligands with reasonably high free and nonspecific binding, the cerebellar cortex should be a useful reference region, provided other necessary radioligand assumptions are met.